Effective treatment of pulmonary adenocarcinoma harboring triple EGFR mutations of L858R, T790M, and cis-C797S by osimertinib, bevacizumab, and brigatinib combination therapy: a case report
Jing Zhao,1 Ming Zou,1 Jinyan Lv,2 Yingmin Han,1 Guangzhi Wang,3 Gang Wang2 1Department of Pharmacy, Affiliated Zhongshan Hospital of Dalian University, Dalian, People’s Republic of China; 2Department of Oncology, Affiliated Zhongshan Hospital of Dalian University, Dalian, People&rsqu...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-09-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/effective-treatment-of-pulmonary-adenocarcinoma-harboring-triple-egfr--peer-reviewed-article-OTT |